The Hypothesis-Led Pricing Framework for PE Value Creation

You closed the deal. The model looks clean, the market is real, and the management team can sell. Now you have 24 to 36 months to turn that thesis into a number your LPs will accept as a MOIC.

The fastest path to earnings before interest, taxes, depreciation and amortization (EBITDA) expansion in a PE-backed (private equity) SaaS company is almost always pricing. Not headcount reduction. Not a new CRM. Pricing. And yet most operating partners still hand this off to the CFO with a benchmark deck from a consulting firm that studied a different vertical three years ago.

The reason it fails is not that pricing is hard. It is that the work starts with an answer instead of a question.

The Margin Leak

When pricing work at a portco begins with conclusions, you buy a set of problems that compound across the hold period.

The first problem is that sales teams reject changes they did not help design. A new pricing tier that arrives from the board without field validation will be bypassed within 45 days. Sales reps will offer extended terms, bundle in implementation credits, or simply quote off-sheet. Your discount rate climbs back to where it was before you spent six figures on the engagement.

The second problem is worse. You lose the signal. When pricing is not governed with consistent controls, the transaction data becomes noise. You cannot tell whether a win came from your new structure or from a rep who made a judgment call. That noise follows you into the next quarter and the next board package.

A portco carrying an uncontrolled 20 to 25 percent average discount rate on a 4x revenue multiple at exit is leaving 0.3 to 0.5 turns of MOIC on the table. Not in theory. In the math your buyer will run on your trailing twelve months.

The Path Forward

A hypothesis-led approach fixes this by treating pricing as an experiment with a defined start, a measurable outcome, and a decision gate before any broad rollout.

Step 1: Write the hypothesis before you touch the price sheet.

The hypothesis is a single sentence that predicts a specific outcome for a specific customer segment. "If we remove the entry-level tier and reposition the base plan at $X per seat, the mid-market segment will show a 12 percent improvement in average contract value with no more than a 5 percent increase in sales cycle length."

That sentence does three things. It names the segment. It predicts a direction and a magnitude. It defines the tradeoff you are willing to accept. If you cannot write that sentence, you are not ready to change the price sheet.

Step 2: Build the smallest possible test.

You do not need to reprice the entire customer base to test the hypothesis. You need 60 to 90 new deals run through the new structure in a single segment, with a clean control group running the old structure in parallel. That is a 30-day experiment in most portcos with an active pipeline.

The test must include deal desk governance. Discount exceptions during the test period invalidate the data. If you cannot hold the line for 30 days you have a sales management problem that will outlast any pricing change.

Step 3: Read the evidence before you decide.

At the end of the test, you have three possible outcomes. The hypothesis was right and you scale. The hypothesis was partially right and you adjust the thesis before scaling. The hypothesis was wrong and you either run a new test or redirect effort to a different lever.

The mistake most portcos make at this stage is confusing "the test did not give us the number we wanted" with "the test failed." A test that kills a bad hypothesis in 30 days saved you a full quarter of misdirected execution and the management distraction that comes with unwinding a change that did not work.

The Wall You'll Hit

A vertical SaaS portco at year 18 months of a 36-month hold period ran a pricing restructure based on a market benchmark showing their lowest tier was priced 30 percent below comparable tools. The operating partner pushed through a 25 percent base price increase across all new business.

Within one quarter, close rates dropped 18 percent. The sales team blamed the price increase. The VP of Sales started approving exceptions to keep deals moving. Within six months the effective price increase in realized revenue was 4 percent, not 25 percent, and the pipeline had thinned because reps were sandbagging deals they expected to lose.

At exit, the portco's net revenue retention (NRR) was 91 percent, down from 97 percent two years earlier. The buyer's model applied a 0.8x multiple discount to forward revenue because of the retention degradation. The exit MOIC was 2.1x on a deal that underwrote to 3.0x.

The failure was not the price increase. Prices needed to move. The failure was that the increase was designed around a competitor benchmark, not a test of what this company's specific customers would pay for this specific product in this specific buying motion.

Actions to Take Now

Pull your portco's pocket price waterfall for the last four quarters. If your CFO cannot produce this in 48 hours, that is your first finding.

Sort every deal by realized price as a percentage of list price. Identify the three largest segments by deal volume. For each segment, calculate the average discount, the range of discounts, and the number of deals that received exceptions above your stated discount ceiling.

What you are looking for is the gap between your pricing policy and your pricing reality. In most portcos this gap is 12 to 20 percentage points. That gap is the hypothesis you need to test first. It is not a pricing problem. It is a governance problem that is masquerading as a pricing problem and costing you margin on every deal.

Once you have that number, write one sentence: "If we close the discount gap from X percent to Y percent through deal desk controls in segment Z, we expect annual contract value (ACV) to improve by $A with no change in close rate above a 5 percent threshold."

That is your first hypothesis. Run it.

For a structured self-assessment of your portco's pricing health, start with the FintastIQ Pricing Diagnostic.

If you are earlier in the process and evaluating commercial health at the diligence stage, see our companion post on commercial due diligence checklists for PE-backed SaaS and our guide to measuring the ROI of pricing work at the portco level.